Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Cadonilimab Combined With Anlotinib Followed by Radiotherapy in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (CAR-RMEC) [Phase 2]
A Phase 2 clinical trial evaluating Cadonilimab in combination with Anlotinib, followed by radiotherapy, for recurrent or metastatic esophag…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial in Esophageal Squamous Cell Carcinoma evaluating a neoantigen-loaded dendritic cell vaccine, potentially in combina…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant adebrelimab for resectable esophageal squamous cell carcinoma, comparing 2 versus 4 cycles; …
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC. [Phase 3]
A Phase 3 trial is evaluating camrelizumab plus neoadjuvant chemotherapy or chemoradiotherapy against chemoradiotherapy alone in resectable …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating adjuvant Sintilimab for locally advanced esophageal squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 trial is evaluating LY01015 plus chemotherapy versus Opdivo plus chemotherapy in advanced or metastatic esophageal squamous cell c…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC [Phase 2]
Phase 2 clinical trial evaluating adebrelimab with or without induction chemotherapy followed by concurrent chemoradiotherapy for unresectab…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer [Phase 2]
Phase 2 clinical trial evaluating Adebrelimab with chemotherapy, endoscopy, and sequential chemoradiotherapy in esophageal squamous cell car…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II exploratory clinical trial evaluating multiple drug combinations for advanced esophageal squamous cell carcinoma; currently recruit…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
Trial evaluating individualized tumor-informed circulating tumor DNA analysis to monitor postoperative recurrence in patients with esophagea…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma [Phase 3]
A Phase 3 trial is evaluating Sintilimab combined with chemotherapy and PEG-rhG-GSF as neoadjuvant therapy for Esophageal Squamous Cell Carc…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation [Phase 2]
Phase 2 study evaluating first-line surufatinib plus serplulimab with standard chemotherapy for advanced solid tumors with neuroendocrine di…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY [NA]
A clinical trial evaluating the combination of TGF-β inhibition and PD-L1 inhibition with chemoradiation for esophageal squamous cell carcin…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Sintilimab and Chemotherapy Sequential Radiotherapy in Advanced Esophageal Cancer [Phase 2, Phase 3]
Clinical trial update for Sintilimab with chemotherapy followed by sequential radiotherapy in metastatic Esophageal Squamous Cell Carcinoma;…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating simmitinib in combination with irinotecan for advanced esophageal squamous cell carcinoma is currently r…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC [Phase 2]
Phase 2 trial evaluating adebrelimab combined with nab-paclitaxel (albumin-bound paclitaxel) and nedaplatin as neoadjuvant therapy for local…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY [Phase 2]
A Phase 2 clinical trial (NCT06354140) evaluating PPIO-008 with tislelizumab and S-1 for patients with ypT+N0 esophageal squamous cell carci…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy [Phase 2]
A Phase 2 clinical trial assessing adjuvant radiotherapy for esophageal squamous cell carcinoma in the era of immunotherapy; recruitment is …
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC [Phase 3]
This is a Phase 3 study evaluating liposomal irinotecan with 5-fluorouracil as second-line therapy for esophageal squamous cell carcinoma; t…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 1]
A Phase 1 clinical trial evaluating liposomal irinotecan with cisplatin and concurrent radiotherapy for locally advanced Esophageal squamous…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Update on a Phase 1b/2 clinical study for advanced or metastatic esophageal squamous cell carcinoma; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC
A prospective cohort study is evaluating neoadjuvant therapy with the PD-1 inhibitor sintilimab plus chemotherapy for resectable esophageal …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study
Clinical trial update about a neoadjuvant chemotherapy-immunotherapy study for resectable esophageal squamous cell carcinoma. The trial is c…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II trial evaluating different radiotherapy doses in combination with sintilimab for locally advanced esophageal squamous cell carcinom…